References
- Biederman J., Wilens T., Mick E., Spencer T., Faraone S. V. Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder. Pediatrics 1999; 104(2)e20, [PUBMED], [INFOTRIEVE]
- http://www.deadiversion.usdoj.gov/arcos/.retail_drug_summary/1999/index.html, Drug Enforcement Administration, Diversion Control Program, Automation of Reports and Consolidated Orders System (ARCOS), 1999, (accessed September, 2002)
- Goldman L. S., Genel M., Bezman R. J., Slanetz P. J. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association. JAMA 1998; 279(14)1100–1107, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Greenhill L. L., Pliszka S., Dulcan M. K., Bernet W., Arnold V., Beitchman J., Benson R. S., Bukstein O., Kinlan J., McClellan J., Rue D., Shaw J. A., Stock S. Practice parameters for the use of stimulant medications in the treatment of children, adolescents, and adults. J. Am. Acad. Child Adolesc. Psychiatry 2002; 41(2 suppl)26S–49S, [PUBMED], [INFOTRIEVE]
- http://www.drugs.indiana.edu/drug_stats/youth99/stats99.html, Indiana Resource Prevention Center. Alcohol, Tobacco, and Other Drug Use by Indiana Children and Adolescents. Bloomington, IN: Institute for Drug Abuse Prevention—1999, (accessed October, 2002)
- Johnston L. D., O'Malley P. M. Issues of validity and population coverage in student surveys of drug use. NIDA Res. Monogr. 1985; 57: 31–54, [PUBMED], [INFOTRIEVE]
- Johnston L. D., O’Malley P. M., Bachman J. G. Monitoring the Future National Survey Results on Drug Use, 1975–2000. Volume I: Secondary School Students. NIH Publication no. 01-4924. Bethesda, MD: NIDA, (2001)
- Johnston L. D., O'Malley P. M., Bachman J. G. Monitoring the Future National Survey Results on Drug Use, 1975–2001. Volume I: Secondary School Students. NIH publication no. 02-5106. Bethesda, MD: NIDA (2002)
- Kollins S. H., MacDonald E. K., Rush C. R. Assessing the abuse potential of methylphenidate in nonhuman and human subjects: a review. Pharmacol. Biochem. Behav. 2001; 68(3)611–627, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Lafever G. B., Dawson K. V., Morrow A. L. The extent of drug therapy for attention deficit-hyperactivity disorder among children in public schools. Am. J. Public Health 1999; 89(9)1359–1364
- McCabe S. E., Boyd C. J., Couper M., Crawford S., d’Arcy H. Mode effects for collecting alcohol and other drug use data: web and U.S. Mail. J. Stud. Alcohol. 2002; 63(6)755–761, [PUBMED], [INFOTRIEVE]
- Musser C. J., Ahmann P. A., Theye F. W., Mundt P., Broste S. K., Mueller-Rizner N. Stimulant use and the potential for abuse in Wisconsin as reported by school administrators and longitudinally followed children. J. Dev. Behav. Pediatr. 1998; 19(3)187–192, [PUBMED], [INFOTRIEVE]
- O'Malley P. M., Bachman J. G., Johnston L. D. Reliability and consistency in self-reports of drug use. Int. J. Addict. 1983; 18(6)805–824, [PUBMED], [INFOTRIEVE]
- Olfson M., Marcus S. C., Weissman M. M., Jensen P. S. National trends in the use of psychotropic mediations by children. J. Am. Acad. Child Adoles. Psychiatry 2002; 41(5)514–521, [CROSSREF]
- Poulin C. Medical and nonmedical stimulant use among adolescents: from sanctioned to unsanctioned use. CMAJ 2001; 165(8)1039–1044, [PUBMED], [INFOTRIEVE]
- Rappley M. D., Gardiner J. C., Jetton J. R., Houang R. T. The use of methylphenidate in Michigan. Arch. Pedriatr. Adolesc. Med. 1995; 149(6)675–679
- Robison L. M., Sclar D. A., Skaer T. L., Galin R. S. National trends in the prevalence of attention-deficit/hyperactivity disorder and the prescribing of methylphenidate among school-age children: 1990–1995. Clin. Pediatr. 1999; 38(4)209–217
- Robison L. M., Skaer T. L., Sclar D. A., Galin R. S. Is attention deficit hyperactivity disorder increasing among girls in the US? Trends in diagnosis and the prescribing of stimulants. CNS Drugs 2002; 16(2)129–137, [PUBMED], [INFOTRIEVE]
- Rushton J. L., Whitmire J. T. Pedriatric stimulant and selective serotonin reuptake inhibitor prescription trends: 1992 to 1998. Arch. Pediatr. Adolesc. Med. 2001; 155(8)560–565, [PUBMED], [INFOTRIEVE]
- Safer D. J., Malever M. Stimulant treatment in Maryland public schools. Pediatrics 2000; 106(3)533–539, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Safer D. J., Zito J. M., Fine E. M. Increased methylphenidate usage for attention deficit disorder in the 1990s. Pediatrics 1996; 98(6)1084–1088, [PUBMED], [INFOTRIEVE]
- Simoni-Wastila L., Tompkins C. Balancing diversion control and medical necessity: the case of prescription drugs with abuse potential. Subst. Use Misuse 2001; 36(9–10)1275–1296, [PUBMED], [INFOTRIEVE]
- Skinner H., Maley O., Smith L., Chirrey S., Morrison M. New frontiers: using the web to engage teens in substance abuse prevention and treatment. Adolescents, Alcohol, and Substance Abuse, P. Monti, S. M. Colby, T. A. O’Leary. Guilford Press, New York 2001; 297–318
- http://www.ses.standardandpoors.com/, Standard and Poor's, School Evaluation Services. (accessed September, 2002)
- Wechsler H., Dowdall G. W., Davenport A., Rimm E. B. A gender-specific measure of binge drinking among college students. Am. J. Public Health 1995; 85(7)982–985, [PUBMED], [INFOTRIEVE]